30.67
전일 마감가:
$28.82
열려 있는:
$28.43
하루 거래량:
247.72K
Relative Volume:
0.17
시가총액:
$2.09B
수익:
$2.76B
순이익/손실:
$-358.70M
주가수익비율:
-6.1704
EPS:
-4.97
순현금흐름:
$-35.90M
1주 성능:
+6.40%
1개월 성능:
-0.54%
6개월 성능:
-31.53%
1년 성능:
-3.56%
Quidelortho Corporation Stock (QDEL) Company Profile
명칭
Quidelortho Corporation
전화
(858) 552-1100
주소
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
QDEL을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
QDEL
Quidelortho Corporation
|
30.67 | 2.09B | 2.76B | -358.70M | -35.90M | -4.97 |
![]()
ABT
Abbott Laboratories
|
136.27 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
104.24 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
396.56 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
88.27 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.35 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-08 | 업그레이드 | Jefferies | Hold → Buy |
2024-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
2024-12-10 | 개시 | Jefferies | Hold |
2024-09-19 | 재개 | UBS | Neutral |
2024-09-05 | 업그레이드 | Craig Hallum | Hold → Buy |
2024-03-04 | 다운그레이드 | UBS | Neutral → Sell |
2024-02-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2023-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
2022-10-14 | 업그레이드 | UBS | Sell → Neutral |
2022-09-19 | 개시 | Citigroup | Neutral |
2022-07-20 | 개시 | UBS | Sell |
2022-06-17 | 재개 | JP Morgan | Neutral |
2022-02-22 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2021-01-22 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2020-05-12 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2020-03-26 | 다운그레이드 | Barclays | Overweight → Equal Weight |
2018-10-23 | 재개 | Raymond James | Strong Buy |
2018-03-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2018-01-22 | 재확인 | Barclays | Overweight |
2018-01-04 | 업그레이드 | CL King | Neutral → Buy |
2017-09-19 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
2017-07-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
2017-07-18 | 업그레이드 | William Blair | Mkt Perform → Outperform |
2017-04-25 | 재확인 | Canaccord Genuity | Hold |
2017-02-17 | 개시 | CL King | Neutral |
2016-12-16 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
2016-06-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2016-02-18 | 재확인 | Barclays | Overweight |
2016-02-09 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
2016-01-08 | 재확인 | Canaccord Genuity | Buy |
2015-12-14 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2015-09-02 | 개시 | Barclays | Overweight |
2013-07-31 | 재확인 | Canaccord Genuity | Buy |
2011-03-03 | 다운그레이드 | Wedbush | Outperform → Neutral |
모두보기
Quidelortho Corporation 주식(QDEL)의 최신 뉴스
What Makes QuidelOrtho (QDEL) a New Buy Stock - Nasdaq
Why QuidelOrtho (QDEL) is a Top Growth Stock for the Long-Term - Yahoo Finance
Should Value Investors Buy QuidelOrtho (QDEL) Stock? - Yahoo Finance
This QuidelOrtho Insider Increased Their Holding In The Last Year - simplywall.st
QuidelOrtho Declares that its Molecular Diagnostics Approach will be Refocused - MSN
Lex seeks FDA clearance ahead of $100M Quidelortho takeover - BioWorld MedTech
QuidelOrtho set to buy LEX Diagnostics for $100m after FDA approval trigger - Cambridge Independent
QuidelOrtho Corp (QDEL) Trading 4% Higher on Jun 9 - GuruFocus
QuidelOrtho seeks FDA approval to complete acquisition of LEX Diagnostics - Mugglehead Magazine
QuidelOrtho (QDEL) Down 18% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment - GlobeNewswire Inc.
Transcript : QuidelOrtho Corporation Presents at Jefferies Global Healthcare Conference 2025, Jun-05-2025 08 - MarketScreener
Transcript : QuidelOrtho Corporation Presents at 45th Annual William Blair Growth Stock Conference, Jun-04-2025 08 - marketscreener.com
QuidelOrtho Corp (QDEL) Stock Price Down 2.92% on Jun 2 - GuruFocus
QuidelOrtho to discontinue Savanna platform development - MSN
QuidelOrtho (QDEL) to Acquire LEX Diagnostics Amid Strategic Shi - GuruFocus
QuidelOrtho shifts focus with LEX Diagnostics deal, drops Savanna By Investing.com - Investing.com South Africa
Transcript : QuidelOrtho CorporationSpecial Call - marketscreener.com
QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics | QDEL Stock News - GuruFocus
QuidelOrtho (QDEL) Shifts Strategy, Plans to Acquire LEX Diagnos - GuruFocus
QuidelOrtho to exit Savanna platform development (QDEL:NASDAQ) - Seeking Alpha
QuidelOrtho shifts focus with LEX Diagnostics deal, drops Savanna - Investing.com
QuidelOrtho announces a refocusing of its molecular diagnostics strategy - TipRanks
QuidelOrtho (QDEL) to acquire full ownership of LEX Diagnostics, announces strategy to accelerate growt - StreetInsider
QuidelOrtho Makes Major Molecular Diagnostics Pivot: $100M LEX Acquisition to Replace Savanna Platform - Stock Titan
Why QuidelOrtho (QDEL) is a Top Momentum Stock for the Long-Term - sharewise
Here's Why QuidelOrtho (QDEL) is a Strong Growth Stock - Yahoo Finance
QuidelOrtho Corp (QDEL) Stock Price Down 3.63% on May 29 - GuruFocus
QuidelOrtho Stockholders Approve Equity Plan Changes - TipRanks
Luxfer, LGI Homes, QuidelOrtho, Dentsply Sirona, and AdaptHealth Stocks Trade Up, What You Need To Know - Yahoo Finance
10,269 Shares in QuidelOrtho Co. (NASDAQ:QDEL) Acquired by BNP Paribas Financial Markets - Defense World
QuidelOrtho’s SWOT analysis: diagnostics firm’s stock faces pivotal year - Investing.com
QuidelOrtho’s SWOT analysis: diagnostics firm’s stock faces pivotal year By Investing.com - Investing.com Canada
Asian Hospital, Faridabad Becomes the First in the City to Launch Total Lab Automation with QuidelOrtho - APN News
QuidelOrtho to Participate in Upcoming June 2025 Investor Conferences - BioSpace
QuidelOrtho to Participate in Upcoming Investor Conferences | QDEL Stock News - GuruFocus
Asian Hospital, Faridabad introduces total lab automation with QuidelOrtho - IndiaMedToday
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now - MSN
QuidelOrtho Management to Present at William Blair and Jefferies Healthcare Conferences Next Month - Stock Titan
Asian Hospital in Faridabad launches total lab automation in partnership with QuidelOrtho - BioSpectrum India
QuidelOrtho Corp (QDEL) Stock Price Down 3.32% on May 19 - GuruFocus
Captrust Financial Advisors Boosts Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
Ameriprise Financial Inc. Has $10.84 Million Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
Quidelortho Corporation (QDEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Quidelortho Corporation 주식 (QDEL) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Blaser Brian J. | President and CEO |
Dec 11 '24 |
Buy |
41.42 |
6,033 |
249,878 |
6,033 |
자본화:
|
볼륨(24시간):